Skip to main content
. 2022 Jan 1;12(3):1061–1073. doi: 10.7150/thno.65299

Figure 3.

Figure 3

Safety evaluation of the DEX-TP treatments. (A and B) Assessment of the organ/body weight ratio (A) and HE staining of key organs (B) after drug treatment in the MIA PaCa-2-derived subcutaneous tumor model. (C and D) Assessment of the organ/body weight ratio (C) and HE staining of key organs (D) after drug treatment in the BxPC-3-derived subcutaneous tumor model. Error bars indicate the mean and SD from at least 3 independent experiments.